Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j.cden.2013.12.007.
PMID:24655527
Hematopoietic stem cell transplantation for acute myeloid leukemia.
Takami A.
Int J Hematol. 2018 May;107(5):513-518. doi: 10.1007/s12185-018-2412-8. Epub 2018 Jan 27.
PMID:29374826
T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease.
Okada S, Muraoka D, Yasui K, Tawara I, Kawamura A, Okamoto S, Mineno J, Seo N, Shiku H, Eguchi S, Ikeda H.
Cancer Sci. 2023 Nov;114(11):4172-4183. doi: 10.1111/cas.15954. Epub 2023 Sep 7.
PMID:37675556
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.
Gyurkocza B, Sandmaier BM.
Blood. 2014 Jul 17;124(3):344-53. doi: 10.1182/blood-2014-02-514778. Epub 2014 Jun 9.
PMID:24914142
Reduced-intensity hematopoietic stem cell transplants for malignancies: harnessing the graft-versus-tumor effect.
Gill S, Porter DL.
Annu Rev Med. 2013;64:101-17. doi: 10.1146/annurev-med-121411-103452. Epub 2012 Oct 29.
PMID:23121181
Graft-versus-cancereffect and innovative approaches in thetreatment of refractory solid tumors.
Şahin U, Demirer T.
Turk J Med Sci. 2020 Nov 3;50(SI-2):1697-1706. doi: 10.3906/sag-1911-112.